By Sheeba M. | May 29, 2026
SAFE Banking Momentum Builds as MSOs Eye June Senate Vote
The cannabis industry’s most anticipated catalyst just moved from “possible” to “probable.” According to multiple Senate staffers briefing institutional investors this week, Democratic leadership has committed sufficient votes for SAFE Banking passage, with a chamber vote expected mid-June. For Curaleaf, Trulieve, and GTI, this translates to immediate relief from predatory 28% APR alternative lending arrangements.
Currently, major MSOs carry $6-9B in short-term debt at rates 8-10x prime, forcing aggressive store closures and delayed expansion. SAFE Banking passage would unlock traditional bank credit lines at 6-8% rates, freeing $2-3B in annual cash for dividends, debt service, and organic growth investments.
The kicker: Republican support appears solid. Sen. Mitch McConnell‘s office confirmed private support in March; GOP members from Oklahoma, Colorado, and Oregon are actively co-sponsoring companion bills in committee. Expect party-line voting to be minimal.
Why This Matters for MSO Valuations
Cannabis MSOs trade at 3-4x EBITDA today, a 60-70% discount to pharma/alcohol peers. SAFE Banking passage removes the single largest regulatory discount. Forward estimates suggest 25-35% upside on MSO valuations within 90 days of bill passage, as institutional capital allocates to the space for the first time.
Watch These Tickers
Track momentum via sentiment on CURLF, TRULP, GTBP, and AYRWF. Expect pre-vote rallies to accelerate 48-72 hours before chamber debate.
Sources
- U.S. Senate Democratic Leadership — Private investor briefings, May 2026
- Politico Cannabis News — Republican support tracking
- Marijuana Company of Canada — Banking impact analysis
Track cannabis stocks with the Weedstock Real-Time Tracker